After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Ironwood Pharmaceuticals Inc (IRWD) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.36, or 3.70%, to $10.10. The Ironwood Pharmaceuticals Inc has recorded 66,690 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Ironwood Pharmaceuticals Reports Third Quarter 2023 Results.
IRWD belongs to the Healthcare sector of the NASDAQ while operating in the Drug Manufacturers – Specialty & Generic industry. At the end of the last regular session, the stock closed at $9.74 and fluctuated between $10.01 as its day high and $9.19 as its day low. The current market capitalization of Ironwood Pharmaceuticals Inc is $1.52B. A total of 2.65 million shares were traded on the day, compared to an average of 2.59M shares.
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, IRWD has seen 4 BUY and 2 SELL insider trades, representing the acquisition of 47,968 and the disposition of 9,021 shares. Over the last 12 months, there were 28 BUYs and 32 SELLs from insiders. Insiders purchased 1,011,655 shares during that period but sold 468,848.
In the most recent transaction, Emany Sravan Kumar bought 36,072 shares of IRWD for 8.32 per share on Sep 15. After the transaction, the SVP, Chief Financial Officer now owns 188,730 company shares. In a previous transaction on Aug 14, John Minardo sold 7,045 shares at 10.04 per share. IRWD shares that Chief Legal Officer owns now total 192,195.
Among the insiders who sold shares, Silver Ronald disposed of 1,976 shares on Aug 14 at a per-share price of $10.04. This resulted in the Principal Accounting Officer holding 134,172 shares of IRWD after the transaction. In another insider transaction, MCCOURT Thomas A sold 26,632 shares at $10.70 per share on May 30. Company shares held by the Chief Executive Officer now total 758,284.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for IRWD in the last 3 months, the mean price target is $17.40 with high estimates of $22.00 and low estimates of $9.00. In terms of 52-week highs and lows, IRWD has a high of $12.66 and a low of $8.07.
As of this writing, IRWD has an earnings estimate of $0.16 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of $0.25 per share and a lower estimate of $0.12. The company reported an EPS of $0.25 in the last quarter, which was 4.20% higher than expectations of $0.24.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. IRWD’s latest balance sheet shows that the firm has $620.13M in Cash & Short Term Investments as of fiscal 2021. There were $475.80M in debt and $161.70M in liabilities at the time. Its Book Value Per Share was -$2.07, while its Total Shareholder’s Equity was $605.91M.
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IRWD is Buy with a score of 4.60.